Replies to post #1477 on Idenix Pharmaceuticals (IDIX)

[randychub]

"Idenix is doing a head to head trials vs both Viread and Baraclude"

Any reason for GILD not to be happy about idix footing the bill for this trial? I imagine if we get similiar result for cost reasons Dr's will choose Hepsera.

Given that Viread and Baraclude work in similiar manners when patients relapse I'am guessing the hope here is that Dr's will put them on Hepsera. Is there any reason to think differently?

Any data yet available to compare Viread/Hepsera for patients relapsing?

Thank You for your time!

Randy

[keitern]

This entire aspect of treatment for HBV is about as clear as mud to me. Combinations and their implications etc. Hope the RMF has a layman's summary of this important aspect of IDIX stock. Thanks